CINECA IRIS Institutional Research Information System

NICOLAZZO, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 936
SA - Sud America 429
NA - Nord America 179
EU - Europa 103
AF - Africa 19
Totale 1.666
Salva come PNG Salva come JPEG
Nazione #
BR - Brasile 329
VN - Vietnam 226
SG - Singapore 223
HK - Hong Kong 206
CN - Cina 154
US - Stati Uniti d'America 145
KR - Corea 75
AR - Argentina 49
FR - Francia 32
MX - Messico 27
EC - Ecuador 18
IT - Italia 16
CO - Colombia 13
DE - Germania 13
BD - Bangladesh 11
ID - Indonesia 10
PL - Polonia 10
RU - Federazione Russa 9
GB - Regno Unito 8
ZA - Sudafrica 7
CL - Cile 6
MA - Marocco 6
IQ - Iraq 5
PY - Paraguay 5
IN - India 4
UA - Ucraina 4
UY - Uruguay 4
UZ - Uzbekistan 4
PK - Pakistan 3
VE - Venezuela 3
DO - Repubblica Dominicana 2
JP - Giappone 2
NL - Olanda 2
PE - Perù 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CA - Canada 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
EG - Egitto 1
ES - Italia 1
FI - Finlandia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
MK - Macedonia 1
MY - Malesia 1
OM - Oman 1
SA - Arabia Saudita 1
SE - Svezia 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TR - Turchia 1
UG - Uganda 1
Totale 1.666
Salva come PNG Salva come JPEG
Città #
Hong Kong 205
Ho Chi Minh City 87
Seoul 75
Singapore 57
Hanoi 41
Ashburn 39
Beijing 39
São Paulo 26
Chicago 22
San Jose 21
Mexico City 18
Haiphong 11
Hillsboro 11
Dallas 10
Warsaw 10
Belo Horizonte 9
Rio de Janeiro 9
Biên Hòa 8
Frankfurt am Main 8
Guayaquil 7
Thái Bình 7
Hải Dương 6
Rome 6
Concordia 5
Da Nang 5
Fortaleza 5
Porto Alegre 5
Bexley 4
Brasília 4
Curitiba 4
Huế 4
New York 4
Osasco 4
Ribeirão Preto 4
Salvador 4
Tashkent 4
Valparaíso de Goiás 4
Belém 3
Buenos Aires 3
Casablanca 3
Guarulhos 3
Ha Long 3
Ipatinga 3
Jakarta 3
Jundiaí 3
Los Angeles 3
Quito 3
São José dos Campos 3
Thái Nguyên 3
Americana 2
Angra dos Reis 2
Arapongas 2
Araçatuba 2
Barretos 2
Basra 2
Belford Roxo 2
Blumenau 2
Bogotá 2
Bắc Giang 2
Bắc Ninh 2
Camacan 2
Camaçari 2
Campinas 2
Canoas 2
Caracas 2
Castelfranco Emilia 2
Catanduva 2
Corrientes 2
Criciúma 2
Cruz Alta 2
Dhaka 2
Fernando de la Mora 2
Florianópolis 2
Guaraciaba 2
Itabira 2
Itu 2
João Pessoa 2
Juiz de Fora 2
La Plata 2
Lima 2
Limeira 2
Medellín 2
Milan 2
Montevideo 2
Natal 2
Niterói 2
Nova Iguaçu 2
Novo Hamburgo 2
Ouricuri 2
Paraisópolis 2
Pelotas 2
Petrópolis 2
Porto Ferreira 2
Ramos Mejía 2
Recife 2
Reston 2
Rio Grande 2
Rio Verde 2
San Bernardo 2
San Miguel de Tucumán 2
Totale 930
Salva come PNG Salva come JPEG
Nome #
A Fast and Furious Liquid Biopsy Assay to Monitor Targeted Therapy Resistance 50
Evolution of Neo-RAS-WT in Circulating Tumor DNA from First-Line to Subsequent Therapies in Metastatic Colorectal Cancer 49
Is cancer an intelligent species? 47
RAS Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based Study 46
Genomic landscape and survival analysis of ctDNA “neo-RAS wild-type” patients with originally RAS mutant metastatic colorectal cancer 42
Circulating Cancer-Associated Macrophage-like Cells as a Blood-Based Biomarker of Response to Immune Checkpoint Inhibitors 40
Circulating methylated dna to monitor the dynamics of ras mutation clearance in plasma from metastatic colorectal cancer patients 38
Circulating tumor cells detection has independent prognostic impact in high-risk non-muscle invasive bladder cancer 37
Genomic landscape and survival analysis of ctDNA “neo-RAS wild-type” patients with originally RAS mutant metastatic colorectal cancer 37
Exploring the utility of a NGS multigene panel to predict BCG response in patients with non-muscle invasive bladder cancer 37
Comparison of two blood-based genotyping tests to investigate the KRAS G12C mutation in patients with non-small-cell lung cancer at failure of first-line treatments 37
Early Detection of Disease Progression in Metastatic Cancers: Could CTCs Improve RECIST Criteria? 36
Blood Extracellular Vesicles Beyond Circulating Tumour Cells: A Valuable Risk Stratification Biomarker in High-Risk Non-Muscle-Invasive Bladder Cancer Patients 36
About RAS Mutation Clearance in Plasma ctDNA From RAS-Mutant Colorectal Cancer Patients 35
Detection of circulating tumor cells in patients with laryngeal cancer using ScreenCell: Comparative pre- and post-operative analysis and association with prognosis 35
An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile 34
The long-term prognostic value of survivin expressing circulating tumor cells in patients with high-risk non-muscle invasive bladder cancer (NMIBC) 34
Why the Therapeutic Impact of RAS Mutation Clearance in Plasma ctDNA Deserves to Be Further Explored in Metastatic Colorectal Cancer 33
Circulating tumor cells isolation: the "post-EpCAM era" 32
Signet ring cell carcinoma of the urinary bladder presenting with carcinocythemia and skeletal metastasis: A case report 31
Circulating tumor cells: exploring intratumor heterogeneity of colorectal cancer 31
Circulating tumor cells in metastatic colorectal cancer: do we need an alternative cutoff? 30
Circulating Tumor Cells in Right- and Left-Sided Colorectal Cancer 29
Transient disappearance of RAS mutant clones in plasma: A counterintuitive clinical use of EGFR inhibitors in RAS mutant metastatic colorectal cancer 29
Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal 29
An Orthotopic Patient-Derived Xenograft (PDX) Model Allows the Analysis of Metastasis-Associated Features in Colorectal Cancer 29
Editorial: Unveiling the potential of CTCs in drug resistance mechanisms and personalized medicine 28
Significance of circulating tumor cells in soft tissue sarcoma 28
Baseline CD44v6-positive circulating tumor cells to predict first-line treatment failure in patients with metastatic colorectal cancer 28
Circulating Tumor Cells Identify Patients with Super-High-Risk Non-Muscle-Invasive Bladder Cancer: Updated Outcome Analysis of a Prospective Single-Center Trial 28
Letter to the Editor: “Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy” 28
Circulating tumor cells count and characterization in a male breast cancer patient 27
Molecular Biomarkers according to Primary Tumor Location in Colorectal Cancer: Current Standard and New Insights 27
Prognostic Role of Circulating Tumor Cell Trajectories in Metastatic Colorectal Cancer 27
Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab 27
Coexistence of three EGFR mutations in an NSCLC patient: A brief report 27
The rationale for liquid biopsy in colorectal cancer: a focus on circulating tumor cells 27
Improving the Nuclear-Localized Androgen Receptor Splice Variant 7 Test 26
Sequential isolation and characterization of single CTCs and large CTC clusters in metastatic colorectal cancer patients 26
Circulating tumor cells and "suspicious objects" evaluated through CellSearch® in metastatic renal cell carcinoma 26
True conversions from RAS mutant to RAS wild-type in circulating tumor DNA from metastatic colorectal cancer patients as assessed by methylation and mutational signature 26
Liquid Biopsy in Rare Cancers: Lessons from Hemangiopericytoma 26
Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational study 25
Impact of chronic exposure to bevacizumab on EpCAM-based detection of circulating tumor cells 24
EpCAM-expressing circulating tumor cells in colorectal cancer 24
EpCAMlow Circulating Tumor Cells: Gold in the Waste 24
Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients 24
Why the therapeutic impact of RAS mutation clearance in plasma ctDNA deserves to be further explored in metastatic colorectal cancer 23
In vitro cultures of circulating tumor cells: a potential tool to unravel drug sensitivity 23
Molecular Characterization of Circulating Tumor Cells to Study Cancer Immunoevasion 23
Prognostic significance of survivin-expressing circulating tumour cells in T1G3 bladder cancer 22
CD133 and ABCB5 as stem cell markers on sentinel lymph node from melanoma patients 22
Effect of Serenoa repens (Permixon®) on the expression of inflammation-related genes: analysis in primary cell cultures of human prostate carcinoma 22
Liquid Biopsy for Predicting Bacillus Calmette-Guérin Unresponsiveness in Non-muscle-invasive Bladder Cancer 21
PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients: A molecular shield to evade immune system? 20
Molecular markers in circulating tumour cells from metastatic colorectal cancer patients 19
Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis 14
The ACCEPTance of automation: refining circulating tumor cells enumeration for improved metastatic colorectal cancer prognosis 13
Prognostic Value of Circulating Tumor Cells and Cancer Associated Macrophage-Like Cells in Metastatic Non-Small Cell Lung Cancer Patients: A Retrospective Exploratory Analysis 7
Totale 1.725
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.415
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.415
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025206 0 0 0 0 0 0 14 16 22 114 31 9
2025/20261.519 167 45 300 419 154 43 39 126 143 83 0 0
Totale 1.725